Total Funding
26
1
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4155313
Bioptix is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic
Stephen T. Lundy: President & CEO
About the Company
Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1 Test. Designed to aid in the identification of patients at low risk for acute appendicitis, the APPY1 Test is a simple, rapid blood test that may help physicians manage the large number of children
and adolescents who enter hospital emergency departments with abdominal pain, suspected of acute appendicitis. Determining whether a patient requires emergency surgery for appendicitis is critical and current practices have important limitations.
